Samarra medicines factory make a qualitative leap in their sales

Baghdad - INA

 The General Company for the manufacture of medicines and medical supplies in Samarra, one of the companies of the Ministry of Industry and Minerals, has revealed a qualitative leap in sales during the past five months, despite health conditions and measures to curb the outbreak of the Coruna epidemic.

 The general manager of the pharmaceutical company, Abd al-Hamid Abd al-Rahman al-Salem, said in a statement received by the Iraqi News Agency (INA): "The company achieved sales of (18) billion (519) million and (349) thousand and (594) dinars for the period of January  Until the month of May 2020, at a rate of evolution (82%) from sales achieved in the same period of last year 2019, amounting to (10) billion (198) million (771) thousand and (442) dinars, which proved the success of the new marketing vision adopted by the Department  The company dramatically. "